Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
San Francisco, CA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
New Haven, CT
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Worcester, MA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Toms River, NJ
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Orangeburg, NY
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Durham, NC
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated:  11/21/2016
Clinical Research Facility
mi
from
Seattle, WA
Study to Assess the Janssen Autism Knowledge Engine in Participants With Autism Spectrum Disorder and in a Normally Developing Cohort
A Study to Assess the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder and in a Normally Developing Cohort
Status: Enrolling
Updated: 11/21/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
Status: Enrolling
Updated:  11/22/2016
Yale Center for Clinical Investigation, Yale Human Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders
Status: Enrolling
Updated: 11/22/2016
Yale Center for Clinical Investigation, Yale Human Behavioral Pharmacology Laboratory
mi
from
New Haven, CT
Click here to add this to my saved trials
Assessing the CenteringPregnancy Planning to Parent Innovation
Assessing the CenteringPregnancy Planning to Parent Innovation
Status: Enrolling
Updated:  11/22/2016
Boston Med Ctr
mi
from
Boston, MA
Assessing the CenteringPregnancy Planning to Parent Innovation
Assessing the CenteringPregnancy Planning to Parent Innovation
Status: Enrolling
Updated: 11/22/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Behavioral Treatment for Substance Abuse
A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems
Status: Enrolling
Updated:  12/1/2016
House of Hope
mi
from
Salt Lake City, UT
Behavioral Treatment for Substance Abuse
A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems
Status: Enrolling
Updated: 12/1/2016
House of Hope
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Behavioral Treatment for Substance Abuse
A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems
Status: Enrolling
Updated:  12/1/2016
Pain Research Center, Anesthesiology, University of Utah
mi
from
Salt Lake City, UT
Behavioral Treatment for Substance Abuse
A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems
Status: Enrolling
Updated: 12/1/2016
Pain Research Center, Anesthesiology, University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Harmonex Neuroscience Research
mi
from
Dothan, AL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Synergy Research
mi
from
National City, CA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Synergy Research
mi
from
National City, CA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
California Clinical Trials
mi
from
Paramount, CA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
California Clinical Trials
mi
from
Paramount, CA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
PCSD - Feighner Research
mi
from
San Diego, CA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
PCSD - Feighner Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Elite Clinical Trials
mi
from
Wildomar, CA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Elite Clinical Trials
mi
from
Wildomar, CA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Sarkis Clinical Trials - Parent
mi
from
Gainesville, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Sarkis Clinical Trials - Parent
mi
from
Gainesville, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Palm Springs Research Institute
mi
from
Hialeah, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
iResearch Atlanta LLC
mi
from
Decatur, GA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Capstone Clinical Research
mi
from
Libertyville, IL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Baber Research Group
mi
from
Naperville, IL
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pedia Research, LLC
mi
from
Newburgh, IN
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pedia Research, LLC
mi
from
Newburgh, IN
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Psychiatric Associates
mi
from
Overland Park, KA
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pedia Research LLC
mi
from
Owensboro, KY
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pedia Research LLC
mi
from
Owensboro, KY
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfied Hills, MI
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Neurobehaviorial Medicine Group, PLLC
mi
from
Bloomfied Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Midwest Research Group
mi
from
St. Charles, MO
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Duke University Medical Center, Duke Child and Family Study Center
mi
from
Durham, NC
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Duke University Medical Center, Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
North Star Medical Research, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
IPS Research Company
mi
from
Oklahoma City, OK
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Cyn3rgy Research
mi
from
Gresham, OR
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
BioBehavioral Research of Austin
mi
from
Austin, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
BioBehavioral Research of Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  12/1/2016
Bayou City Research Corporation
mi
from
Houston, TX
Dasotraline Pediatric ADHD Study
A 6-week, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-group Efficacy and Safety Study of Dasotraline Versus Placebo in Subjects 6 to 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 12/1/2016
Bayou City Research Corporation
mi
from
Houston, TX
Click here to add this to my saved trials